Bordetella pertussis detection by PCR in nasopharynx

Test Code
PERT


Alias/See Also
LOINC 43913-3


CPT Codes
87798

Preferred Specimen
Nasopharyngeal Swabs:
  1. Polyester
  2. Rayon
  3. Flocked Nylon
Transport Media:
  1. Liquid Amies
  2. Liquid Stuart
  3. Sterile container (red top tube)
Collection system:
  1. Copan Transport System
  2. Eswab


Transport Temperature
Preferred refrigerated


Specimen Stability

Unpreserved samples or samples stored in transport media should be tested as soon as possible, but may be held at room temperature (21-30°C) for up to 5 days or refrigerated (2-8°C) for up to 7 days prior to testing. Do not freeze samples.




Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Throat
Nares/Nasal
Liquid Amies w/charcoal


Methodology
PCR  (Meridian BioScience Alethia Pertussis)

Report Available
Routine: 24 Hour TAT      STAT: 2 Hours (between the hours of 7am – 9pm)


Limitations
  • Aspirin was found to interfere with Alethia Pertussis testing at concentrations greater than 5 mg/mL.
  • The Alethia Pertussis assay targets the IS481 insertional element of Bordetella genome.The IS481insertional element is present in B. pertussis, B. holmesii and some strains of B. bronchiseptica.
  • The Alethia Pertussis DNA assay is a qualitative assay and does not provide quantitative values or information about organism load.
  • This device has not been evaluated for the monitoring treatment of Bordetella pertussis infections.
  • This test has not been evaluated for specimens other than nasopharyngeal swab specimens.
  • B. parapertussis which causes pertussis-like illness is not detected by the Alethia Pertussis DNA assay.  Illness caused by B. parapertussis is generally milder than illness caused by B. pertussis because the organism does not produce pertussis toxin.
  • Positive results do not preclude co-infection with other respiratory pathogens.
  • False-negative B. pertussis results are more likely if patients are tested later in the disease course (more than 2 weeks after symptom onset), due to declining Bordetella DNA. False-negative results may also be increased in patients treated with antibiotics.
  • Environmental contamination of an exam room from a prior patient or a recent pertussis vaccination administration may result in false-positive result.
  • The detection of nucleic acid is dependent upon proper specimen collection, handling, transportation, storage and preparation.Failure to observe proper procedure in any one of these steps can lead to incorrect results.


Reference Range

Reference Range:
Negative

Reportable Range:
Positive: Sample contains B. pertussis target DNA



Negative: No B. pertussis DNA detected OR Below limit of detection



Invalid: Interfering substances

 




Clinical Significance
Qualitative test for the direct detection of Bordetella pertussis in human nasopharyngeal swab samples taken from patients suspected of having respiratory tract infection attributed to B. pertussis.


Performing Laboratory
York Hospital



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.